ULTRAJECT: IOVERSOL INJECTION.
The IOVERSOL INJECTION is a the manufacturer industrial component. Key specifications include primary_container_type: SYRINGE, total_primary_container_quantity: 20, primary_container_content_quantity: 50.000 MILLILITERS, part_name_assigned_by_controlling_agency: IOVERSOL INJECTION 50ML SYRINGE 20S. This part is cataloged in the U.S.
Government catalog under NSN 6505-01-354-3162, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.
Verify compatibility with your specific system configuration before ordering.
| primary_container_type | SYRINGE |
| total_primary_container_quantity | 20 |
| primary_container_content_quantity | 50.000 MILLILITERS |
| part_name_assigned_by_controlling_agency | IOVERSOL INJECTION 50ML SYRINGE 20S |
| NSN | 6505-01-354-3162 |
| PRIMARY CONTAINER CONTENT QUANTITY | 50.000 MILLILITERS |
| PRIMARY CONTAINER TYPE | SYRINGE |
| SPECIAL FEATURES | INTRAVENOUS CONTRAST SYRINGE; PREFILLED UNIT DOSE; HAND-HELD; 68 PERCENT IOVERSAL ACTIVE INGREDIENT 678 MG/ML. STORE AT 25 DEG C (77 DEG F); EXCURSIONS PERMITTED TO 15-30 DEG C(59-86 DEG F) (SEE USP CONTROLLED ROOM TEMPERATURE). MAY BE STORED UP TO 40 DEG C FOR UP TO ONE MONTH IN A CONTRAST MEDIA WARMER UTILIZING CIRCULATING WARM AIR. WHEN STORING FOR PERIODS LONGER THAN ONE MONTH, STORE AT 25 DEG C (77 DEG F); EXCURSIONS PERMITTED TO 15-30 DEG C (59-86 DEG F) (SEE USP CONTROLLED ROOM TEMPERATURE). DEGC |
| PART NAME ASSIGNED BY CONTROLLING AGENCY | IOVERSOL INJECTION 50ML SYRINGE 20S |
| TOTAL PRIMARY CONTAINER QUANTITY | 20 |